What is Kalion?
Kalion, Inc. operates at the intersection of sustainable chemistry and industrial manufacturing. The company specializes in the production of high-purity chemicals derived from biomass, with a primary focus on high-purity glucaric acid. This innovative approach allows Kalion to serve diverse markets, including industrial water treatment, materials enhancement, and the pharmaceutical sector. By utilizing proprietary fermentation techniques, the firm provides a sustainable alternative to traditional chemical synthesis, effectively addressing the growing demand for bio-based materials that do not compromise on performance or purity. Their market position is defined by a commitment to replacing petroleum-derived inputs with renewable, biomass-based solutions, thereby enabling their clients to meet stringent environmental and performance standards.
How much funding has Kalion raised?
Kalion has raised a total of $1.7M across 2 funding rounds:
Private Equity
$697K
Private Equity
$1M
Private Equity (2015): $697K, investors not publicly disclosed
Private Equity (2017): $1M led by Cherrystone Angel Group
Key Investors in Kalion
Cherrystone Angel Group
Cherrystone Angel Group is an investment firm that focuses on providing capital to early-stage companies primarily in New England across various sectors, including life sciences, software, healthcare, and fintech.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Kalion?
With this recent capital, Kalion is well-positioned to scale its manufacturing capabilities and expand its footprint within the global chemical supply chain. The strategic focus will likely shift toward optimizing production yields and deepening partnerships within the pharmaceutical and materials sectors. As the industry pivots toward greener alternatives, Kalion's ability to deliver high-purity, bio-based chemicals at scale will be a key driver of its long-term growth. Future milestones will likely involve the expansion of their fermentation infrastructure and the pursuit of new applications for their glucaric acid platform, ensuring the company remains at the forefront of the bio-industrial revolution.
See full Kalion company page
